Literature DB >> 33753734

The release of toxic oligomers from α-synuclein fibrils induces dysfunction in neuronal cells.

Roberta Cascella1, Serene W Chen2,3, Alessandra Bigi1, José D Camino4, Catherine K Xu3, Christopher M Dobson3, Fabrizio Chiti1, Nunilo Cremades5, Cristina Cecchi6.   

Abstract

The self-assembly of α-synuclein (αS) into intraneuronal inclusion bodies is a key characteristic of Parkinson's disease. To define the nature of the species giving rise to neuronal damage, we have investigated the mechanism of action of the main αS populations that have been observed to form progressively during fibril growth. The αS fibrils release soluble prefibrillar oligomeric species with cross-β structure and solvent-exposed hydrophobic clusters. αS prefibrillar oligomers are efficient in crossing and permeabilize neuronal membranes, causing cellular insults. Short fibrils are more neurotoxic than long fibrils due to the higher proportion of fibrillar ends, resulting in a rapid release of oligomers. The kinetics of released αS oligomers match the observed kinetics of toxicity in cellular systems. In addition to previous evidence that αS fibrils can spread in different brain areas, our in vitro results reveal that αS fibrils can also release oligomeric species responsible for an immediate dysfunction of the neurons in the vicinity of these species.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33753734     DOI: 10.1038/s41467-021-21937-3

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   14.919


  49 in total

Review 1.  The contribution of biophysical and structural studies of protein self-assembly to the design of therapeutic strategies for amyloid diseases.

Authors:  Nunilo Cremades; Christopher M Dobson
Journal:  Neurobiol Dis       Date:  2017-07-12       Impact factor: 5.996

2.  Detection of elevated levels of α-synuclein oligomers in CSF from patients with Parkinson disease.

Authors:  T Tokuda; M M Qureshi; M T Ardah; S Varghese; S A S Shehab; T Kasai; N Ishigami; A Tamaoka; M Nakagawa; O M A El-Agnaf
Journal:  Neurology       Date:  2010-10-20       Impact factor: 9.910

3.  Metastability of native proteins and the phenomenon of amyloid formation.

Authors:  Andrew J Baldwin; Tuomas P J Knowles; Gian Gaetano Tartaglia; Anthony W Fitzpatrick; Glyn L Devlin; Sarah Lucy Shammas; Christopher A Waudby; Maria F Mossuto; Sarah Meehan; Sally L Gras; John Christodoulou; Spencer J Anthony-Cahill; Paul D Barker; Michele Vendruscolo; Christopher M Dobson
Journal:  J Am Chem Soc       Date:  2011-08-19       Impact factor: 15.419

4.  Causal relation between alpha-synuclein gene duplication and familial Parkinson's disease.

Authors:  P Ibáñez; A-M Bonnet; B Débarges; E Lohmann; F Tison; P Pollak; Y Agid; A Dürr; A Brice
Journal:  Lancet       Date:  2004 Sep 25-Oct 1       Impact factor: 79.321

5.  Structural basis of membrane disruption and cellular toxicity by α-synuclein oligomers.

Authors:  Giuliana Fusco; Serene W Chen; Philip T F Williamson; Roberta Cascella; Michele Perni; James A Jarvis; Cristina Cecchi; Michele Vendruscolo; Fabrizio Chiti; Nunilo Cremades; Liming Ying; Christopher M Dobson; Alfonso De Simone
Journal:  Science       Date:  2017-12-15       Impact factor: 47.728

6.  Kinetic model of the aggregation of alpha-synuclein provides insights into prion-like spreading.

Authors:  Marija Iljina; Gonzalo A Garcia; Mathew H Horrocks; Laura Tosatto; Minee L Choi; Kristina A Ganzinger; Andrey Y Abramov; Sonia Gandhi; Nicholas W Wood; Nunilo Cremades; Christopher M Dobson; Tuomas P J Knowles; David Klenerman
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-16       Impact factor: 11.205

7.  Structural characterization of toxic oligomers that are kinetically trapped during α-synuclein fibril formation.

Authors:  Serene W Chen; Srdja Drakulic; Emma Deas; Myriam Ouberai; Francesco A Aprile; Rocío Arranz; Samuel Ness; Cintia Roodveldt; Tim Guilliams; Erwin J De-Genst; David Klenerman; Nicholas W Wood; Tuomas P J Knowles; Carlos Alfonso; Germán Rivas; Andrey Y Abramov; José María Valpuesta; Christopher M Dobson; Nunilo Cremades
Journal:  Proc Natl Acad Sci U S A       Date:  2015-04-08       Impact factor: 11.205

8.  Direct observation of the interconversion of normal and toxic forms of α-synuclein.

Authors:  Nunilo Cremades; Samuel I A Cohen; Emma Deas; Andrey Y Abramov; Allen Y Chen; Angel Orte; Massimo Sandal; Richard W Clarke; Paul Dunne; Francesco A Aprile; Carlos W Bertoncini; Nicholas W Wood; Tuomas P J Knowles; Christopher M Dobson; David Klenerman
Journal:  Cell       Date:  2012-05-25       Impact factor: 41.582

9.  Direct visualization of alpha-synuclein oligomers reveals previously undetected pathology in Parkinson's disease brain.

Authors:  Rosalind F Roberts; Richard Wade-Martins; Javier Alegre-Abarrategui
Journal:  Brain       Date:  2015-03-01       Impact factor: 13.501

10.  Dopamine induces soluble α-synuclein oligomers and nigrostriatal degeneration.

Authors:  Danielle E Mor; Elpida Tsika; Joseph R Mazzulli; Neal S Gould; Hanna Kim; Malcolm J Daniels; Shachee Doshi; Preetika Gupta; Jennifer L Grossman; Victor X Tan; Robert G Kalb; Kim A Caldwell; Guy A Caldwell; John H Wolfe; Harry Ischiropoulos
Journal:  Nat Neurosci       Date:  2017-09-18       Impact factor: 24.884

View more
  23 in total

1.  Mechanistic Kinetic Model Reveals How Amyloidogenic Hydrophobic Patches Facilitate the Amyloid-β Fibril Elongation.

Authors:  Hengyi Xie; Ana Rojas; Gia G Maisuradze; George Khelashvili
Journal:  ACS Chem Neurosci       Date:  2022-03-08       Impact factor: 4.418

2.  Bivalent metal ions induce formation of α-synuclein fibril polymorphs with different cytotoxicities.

Authors:  Deyhim Atarod; Fatemeh Mamashli; Atiyeh Ghasemi; Faezeh Moosavi-Movahedi; Mitra Pirhaghi; Hadi Nedaei; Vladimir Muronetz; Thomas Haertlé; Jörg Tatzelt; Gholamhossein Riazi; Ali Akbar Saboury
Journal:  Sci Rep       Date:  2022-07-13       Impact factor: 4.996

3.  Inhibition of alpha-synuclein aggregation by AM17, a synthetic resveratrol derivative.

Authors:  Edward Chau; Hyunjoo Kim; Jineun Shin; Alberto Martinez; Jin Ryoun Kim
Journal:  Biochem Biophys Res Commun       Date:  2021-08-20       Impact factor: 3.322

4.  Exploring Structural Flexibility and Stability of α-Synuclein by the Landau-Ginzburg-Wilson Approach.

Authors:  Anatolii Korneev; Alexander Begun; Sergei Liubimov; Khatuna Kachlishvili; Alexander Molochkov; Antti J Niemi; Gia G Maisuradze
Journal:  J Phys Chem B       Date:  2022-09-02       Impact factor: 3.466

5.  Library-Derived Peptide Aggregation Modulators of Parkinson's Disease Early-Onset α-Synuclein Variants.

Authors:  Kathryn J C Watt; Richard M Meade; Robert J Williams; Jody M Mason
Journal:  ACS Chem Neurosci       Date:  2022-05-25       Impact factor: 5.780

6.  Co-aggregation and secondary nucleation in the life cycle of human prolactin/galanin functional amyloids.

Authors:  Debdeep Chatterjee; Reeba S Jacob; Soumik Ray; Ambuja Navalkar; Namrata Singh; Shinjinee Sengupta; Laxmikant Gadhe; Pradeep Kadu; Debalina Datta; Ajoy Paul; Sakunthala Arunima; Surabhi Mehra; Chinmai Pindi; Santosh Kumar; Praful Singru; Sanjib Senapati; Samir K Maji
Journal:  Elife       Date:  2022-03-08       Impact factor: 8.713

Review 7.  Modeling the cellular fate of alpha-synuclein aggregates: A pathway to pathology.

Authors:  Nicholas P Marotta; Virginia M-Y Lee
Journal:  Curr Opin Neurobiol       Date:  2022-02-04       Impact factor: 7.070

Review 8.  Lymphoblastoid Cell Lines as Models to Study Mitochondrial Function in Neurological Disorders.

Authors:  Sarah Jane Annesley; Paul Robert Fisher
Journal:  Int J Mol Sci       Date:  2021-04-26       Impact factor: 5.923

9.  α-synuclein-assisted oligomerization of β-amyloid (1-42).

Authors:  Edward Chau; Jin Ryoun Kim
Journal:  Arch Biochem Biophys       Date:  2022-01-15       Impact factor: 4.013

10.  Exploring the Release of Toxic Oligomers from α-Synuclein Fibrils with Antibodies and STED Microscopy.

Authors:  Alessandra Bigi; Emilio Ermini; Serene W Chen; Roberta Cascella; Cristina Cecchi
Journal:  Life (Basel)       Date:  2021-05-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.